US FDA accepts Samsung Bioepis' application for Humira biosimilar

/0 Comments/in /by

… anti-tumor necrosis factor monoclonal antibody that currently treats Crohn's disease, rheumatoid arthritis, ulcerative colitis, hidradenitis suppurativa, …

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *